Patent · US Active

Fused pyrimidine derivatives

US10730881B2 · kind B2 · utility

2Cited by

0References

13Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Bjoern Bartels · Schopfheim, DE
Roland Jakob-Roetne · Inzlingen, DE
Anja Limberg · Penzberg, DE
Werner Neidhart · Hagenthal-le-Bas, FR
Hasane Ratni · Habsheim, FR
Michael Reutlinger · Glückstadt, DE
Sandra Steiner · Atlanta, US

Key dates

Filing date	Jan 10, 2019
Grant date	Aug 4, 2020
Priority date	—
Expiry date	Jan 10, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to a compound of formula I wherein The compounds may be used for the treatment of Alzheimer's disease, cerebral amyloid angiopathy, hereditary cerebral hemorrhage with amyloidosis, Dutch-type (HCHWA-D), multi-infarct dementia, dementia pugilistica or Down syndrome.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.